Open AccessParvovirus B19 ‐associated graft failure after allogeneic hematopoietic stem cell transplantation
Author(s) -
Rattani Nabila,
Matheny Christina,
Eckrich Michael J.,
Madden Lisa M.,
Quigg Troy C.
Publication year - 2022
Publication title -
cancer reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.261
H-Index - 5
ISSN - 2573-8348
DOI - 10.1002/cnr2.1403
Subject(s) - medicine , hematopoietic stem cell transplantation , etiology , transplantation , parvovirus , confounding , immunology , virus
Abstract Background Parvovirus B19 (PVB19) infection has been implicated in allograft failure or dysfunction in solid organ transplantation (SOT) and allogeneic hematopoietic stem cell transplantation (allo‐HSCT), but the literature is limited. Case Two pediatric patients were diagnosed with PVB19 infection around the time of allo‐HSCT graft failure. Both cases were secondary graft failure and required second allo‐HSCT. Conclusion There are many risk factors and potential confounders in determining the exact etiology of graft failure after allo‐HSCT. These two cases highlight the importance of including PVB19 in the diagnostic evaluation for graft failure. PVB19 infection may be an important risk factor for allo‐HSCT graft failure.